Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million

WALD•2026-07-30

Focus shifts to Milk Makeup

The group will focus on accelerating global growth at Milk Makeup, its remaining brand.

Leadership at Obagi Medical

Founders Michel Brousset and Hind Sebti, alongside CFO Manuel Manfredi, will move to lead Obagi Medical with Bridgepoint. Executive Chairman Felipe Dutra will serve as principal executive officer and principal financial officer.

Sale of Obagi Medical completed

Waldencast completed the sale of Obagi Medical to Bridgepoint in a deal valued at up to USD 460 million, subject to customary closing adjustments.

Balance sheet strengthened with proceeds

Proceeds were used to repay all outstanding senior term loan facility borrowings, strengthening the balance sheet.

Sources

Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million

Publicnow

Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million

Focus shifts to Milk Makeup

Leadership at Obagi Medical

Sale of Obagi Medical completed

Balance sheet strengthened with proceeds

Related News

Heritage Financial EVP Chief Banking Officer Kelli Ann Wilson sells 3,778 common shares for $112,182.05

Toppoint Holdings announces annual shareholder meeting

Santander plans share exchange offer for remaining 10% stake in Santander Brazil, valuing deal at up to EUR 1.91 billion

Sources

Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million

Forum Energy Technologies Q2 2026 net income rises 61% to $12.41 million; revenue increases 8% to $226.22 million

Vale starts commissioning Serra Sul +20 iron ore expansion project in Brazil